Table 1.
Patient no. | Age range | Eye | Preoperative lens status | MH diameter (μm) | Operative procedure | Tamponade | Preoperative BCVA (decimal) |
---|---|---|---|---|---|---|---|
Group 1 | |||||||
1 | 70–74 | R | IOL | 598 | PPV, PL | C2F6 | 0.2 |
2 | 75–79 | R | IOL | 652 | PPV, PL | C2F6 | 0.01 |
3 | 75–79 | L | IOL | 479 | PPV, PL | C2F6 | 0.2 |
4 | 60–64 | R | Phake | 753 | PPV, PL, PEA, IOL | C2F6 | 0.1 |
5 | 75–79 | R | IOL | 451 | PPV, PL | C2F6 | 0.1 |
6 | 65–69 | L | IOL | 505 | PPV, PL | C2F6 | 0.2 |
7 | 55–59 | L | IOL | 697 | PPV, PL | C2F6 | 0.05 |
8 | 60–64 | R | IOL | 500 | PPV, PL | C2F6 | 0.2 |
9 | 65–69 | L | Phake | 1028 | PPV, PL, PEA, IOL | C2F6 | 0.05 |
10 | 70–74 | R | Phake | 479 | PPV, PL, PEA, IOL | C2F6 | 0.15 |
11 | 65–69 | L | Phake | 401 | PPV, PL, PEA, IOL | C2F6 | 0.2 |
12 | 70–74 | R | IOL | 603 | PPV, PL | C2F6 | 0.1 |
13 | 60–64 | R | IOL | 401 | PPV, PL | C2F6 | 0.05 |
14 | 70–74 | L | IOL | 654 | PPV, PL | C2F6 | 0.2 |
15 | 75–79 | L | IOL | 400 | PPV, PL | C2F6 | 0.1 |
16 | 50–54 | R | Phake | 879 | PPV, PL, PEA, IOL | C2F6 | 0.05 |
17 | 60–64 | R | IOL | 695 | PPV, PL | C2F6 | 0.05 |
18 | 65–69 | R | IOL | 450 | PPV, PL | C2F6 | 0.05 |
19 | 60–64 | L | IOL | 508 | PPV, PL | C2F6 | 0.1 |
20 | 70–74 | R | IOL | 400 | PPV, PL | C2F6 | 0.15 |
21 | 65–69 | R | Phake | 400 | PPV, PL, PEA, IOL | C2F6 | 0.1 |
22 | 65–69 | R | IOL | 650 | PPV, PL | C2F6 | 0.05 |
23 | 60–64 | R | Phake | 621 | PPV, PL, PEA, IOL | C2F6 | 0.1 |
Group 2 | |||||||
1 | 65–69 | L | IOL | 426 | PPV, ILM | C2F6 | 0.12 |
2 | 70–74 | L | IOL | 432 | PPV, ILM | C2F6 | 0.3 |
3 | 65–69 | R | Phake | 502 | PPV, ILM, PEA, IOL | C2F6 | 0.16 |
4 | 65–69 | R | IOL | 571 | PPV, ILM | C2F6 | 0.1 |
5 | 65–69 | R | IOL | 575 | PPV, ILM | C2F6 | 0.08 |
6 | 70–74 | L | IOL | 573 | PPV, ILM | C2F6 | 0.1 |
7 | 75–79 | R | Phake | 593 | PPV, ILM, PEA, IOL | C2F6 | 0.16 |
8 | 65–69 | L | IOL | 640 | PPV, ILM | C2F6 | 0.04 |
9 | 70–74 | R | IOL | 642 | PPV, ILM | C2F6 | 0.16 |
10 | 60–64 | R | IOL | 694 | PPV, ILM | C2F6 | 0.08 |
11 | 65–69 | L | IOL | 699 | PPV, ILM | C2F6 | 0.08 |
12 | 60–64 | L | Phake | 691 | PPV, ILM, PEA, IOL | C2F6 | 0.04 |
13 | 65–69 | R | Phake | 739 | PPV, ILM, PEA, IOL | C2F6 | 0.08 |
14 | 45–49 | L | IOL | 746 | PPV, ILM | C2F6 | 0.16 |
15 | 75–79 | L | Phake | 798 | PPV, ILM, PEA, IOL | C2F6 | 0.1 |
16 | 60–64 | R | IOL | 792 | PPV, ILM | C2F6 | 0.16 |
17 | 75–79 | L | IOL | 833 | PPV, ILM | C2F6 | 0.16 |
18 | 70–74 | R | IOL | 891 | PPV, ILM | C2F6 | 0.1 |
19 | 40–44 | L | IOL | 1159 | PPV, ILM | C2F6 | 0.1 |
20 | 55–59 | R | Phake | 674 | PPV, ILM, PEA, IOL | C2F6 | 0.05 |
21 | 75–79 | R | IOL | 721 | PPV, ILM | C2F6 | 0.1 |
22 | 55–59 | R | IOL | 438 | PPV, ILM | C2F6 | 0.25 |
23 | 65–69 | R | IOL | 524 | PPV, ILM | C2F6 | 0.1 |
Abbreviations: BCVA best-corrected visual acuity, C2F8 hexafluoroethane, ILM Inverted ILM flap, IOL intraocular lens, LogMAR logarithm of minimum angle of resolution, MH macular hole, PEA phacoemulsification, PPV pars plana vitrectomy